Search clinical trials for: Empagliflozin
Total 926 results
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Korea, Republic of, China, Germany, Belgium, Australia, Italy, United Kingdom, Argentina, Hungary, Czechia, Poland, Netherlands, Japan, Mexico, India, Brazil, France
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Germany, Greece, Australia, Sweden, Italy, Norway, Poland, Portugal
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
Boehringer IngelheimEli Lilly and CompanyCompletedHypertension | Diabetes Mellitus, Type 2United States, Canada, Czech Republic, Denmark, Estonia, Finland, France, Germany, Lebanon, Netherlands, Norway, Sweden
-
Boehringer IngelheimCompleted
-
Aristotle University Of ThessalonikiRecruitingCardiovascular Prevention | Tissue Oxygenation | Empagliflozin | SGLT2-Inhibitors | Hematocrit ChangeGreece
-
Hull University Teaching Hospitals NHS TrustCompleted
-
Oregon State UniversitySamaritan Health ServicesRecruitingPreDiabetes | Prediabetic State | Overweight and ObesityUnited States
-
University of PisaCompletedEnd Stage Renal DiseaseItaly
-
Boehringer IngelheimCompleted
-
Ministry of Health and Population, EgyptCompleted
-
University Hospital, Gentofte, CopenhagenEli Lilly and CompanyCompleted
-
Institut für Pharmakologie und Präventive MedizinUniversity of Erlangen-Nürnberg Medical SchoolCompletedDiabetes Mellitus Type 2Germany
-
Ain Shams UniversityNot yet recruitingNephrotic Syndrome
-
The University of The West IndiesCompletedPlatelet Dysfunction Due to DrugsTrinidad and Tobago
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Argentina, Croatia, Estonia, Germany, Italy, Korea, Republic of, Lithuania, Romania, Russian Federation, Slovakia, Sweden, Taiwan, Ukraine
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Korea, Republic of, China, Germany, Belgium, Australia, Singapore, Canada, Italy, Argentina, Hungary, Czechia, Poland, Netherlands, Japan, United Kingdom, Mexico, Romania, Brazil, India, South Africa, Colombia
-
Novartis PharmaceuticalsTerminatedDiabetes Mellitus and Heart FailureUnited States, Belgium, Austria, Croatia, Czechia, Netherlands, Canada, Korea, Republic of, Taiwan, Hungary, United Kingdom, Italy, Bulgaria, Germany, Argentina, Ireland, Norway, Spain, Denmark, Singapore, South Africa, Mexico, Poland, Puerto Rico
-
Jichi Medical UniversityEli Lilly and Company; Boehringer IngelheimCompletedT2DM (Type 2 Diabetes Mellitus) | Nocturnal HypertensionJapan
-
Children's Hospital of Fudan UniversityWithdrawnChronic Kidney Diseases | ProteinuriaChina
-
University of PisaUnknownGlucose Metabolism Disorders | Renal Function DisorderItaly
-
The University of Hong KongNot yet recruitingChronic Kidney Diseases | Lupus NephritisHong Kong
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesCzech Republic, Korea, Republic of, Hungary, Poland, Ukraine, Philippines, Thailand
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States
-
University of LeicesterUniversity Hospitals, Leicester; Loughborough UniversityCompletedDiabetes Mellitus, Type 2United Kingdom
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, Greece, India, Philippines, Thailand, Ukraine
-
University of DiyalaCompleted
-
The Deutsche Diabetes Forschungsgesellschaft e.V.Boehringer IngelheimCompletedType 2 Diabetes | Non-alcoholic Fatty Liver DiseaseGermany
-
Boehringer IngelheimCompleted
-
Dasman Diabetes InstituteCompleted
-
Inventiva PharmaActive, not recruitingDiabetes Mellitus, Type 2 | NASH - Nonalcoholic SteatohepatitisUnited States, Belgium, France, Netherlands, United Kingdom
-
Metacrine, Inc.Active, not recruitingDiabetes | Fatty Liver | Type 2 Diabetes | NAFLD | NASH - Nonalcoholic Steatohepatitis | Diabetes Type 2 | NASH | Fatty Liver, NonalcoholicUnited States
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Germany
-
University at BuffaloCompletedType 1 Diabetes MellitusUnited States
-
AstraZenecaCompletedType 2 Diabetes MellitusIndia
-
SK Chemicals Co., Ltd.CompletedHealthy SubjectsKorea, Republic of
-
Getz PharmaCompletedType II Diabetes MellitusPakistan
-
National and Kapodistrian University of AthensHippocration General Hospital; Alexandra Hospital, Athens, GreeceCompletedLiver Steatosis | Non-Alcoholic Fatty Liver DiseaseGreece
-
Yonsei UniversityCompletedType 2 Diabetes MellitusKorea, Republic of
-
Amir MoheetRecruitingCystic Fibrosis | Cystic Fibrosis-related DiabetesUnited States
-
Instituto Nacional de Cardiologia Ignacio ChavezBoehringer Ingelheim laboratoryNot yet recruitingHeart Failure | Congenital Heart Disease | Heart Failure With Reduced Ejection FractionMexico
-
Asmaa Abdelfattah ElsayedCompleted
-
Population Health Research InstituteAstraZenecaCompletedType 2 Diabetes MellitusCanada
-
Boryung Pharmaceutical Co., LtdCompleted
-
University of UtahNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingHemodialysis | Kidney Disease, Chronic | Kidney Failure | Dialysis | Diabetic | End-stage Kidney Disease | Kidney Dysfunction | Non-diabeticUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
University of OklahomaGlaxoSmithKlineTerminatedRecurrent Glioblastoma | Recurrent Glioma | Recurrent Astrocytoma | Recurrent OligodendrogliomaUnited States